Literature DB >> 20571486

HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22.

M Bodd1, M Ráki, S Tollefsen, L E Fallang, E Bergseng, K E A Lundin, L M Sollid.   

Abstract

We have analyzed the production of the effector cytokines interleukin (IL)-17, IL-21, and IL-22 in gluten-reactive CD4(+) T cells of celiac disease patients, either cultured from small intestinal biopsies or isolated from peripheral blood after an oral gluten challenge. Combining intracellular cytokine staining with DQ2-α-II gliadin peptide tetramer staining of intestinal polyclonal T-cell lines, we found that gluten-specific T cells produced interferon-γ (IFN-γ) and IL-21, but not IL-17 or IL-22, even if other T cells of the same lines produced these cytokines. Similarly, in DQ2-α-II-specific T cells in peripheral blood of gluten-challenged patients, very few stained for intracellular IL-17, whereas many cells stained for IFN-γ. We conclude that gluten-reactive T cells produce IL-21 and IFN-γ, but not IL-17. Their production of IL-21 suggests a role for this cytokine in the pathogenesis of celiac disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20571486     DOI: 10.1038/mi.2010.36

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  47 in total

1.  Short wheat challenge is a reproducible in-vivo assay to detect immune response to gluten.

Authors:  A Camarca; G Radano; R Di Mase; G Terrone; F Maurano; S Auricchio; R Troncone; L Greco; C Gianfrani
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

Review 2.  Celiac disease: from etiological factors to evolving diagnostic approaches.

Authors:  Anantdeep Kaur; Olga Shimoni; Michael Wallach
Journal:  J Gastroenterol       Date:  2017-06-19       Impact factor: 7.527

3.  Interleukin-21-mediated TLR4 activation in celiac disease.

Authors:  Se Jin Park; Jae Il Shin
Journal:  Dig Dis Sci       Date:  2013-07-05       Impact factor: 3.199

Review 4.  The light and dark sides of intestinal intraepithelial lymphocytes.

Authors:  Hilde Cheroutre; Florence Lambolez; Daniel Mucida
Journal:  Nat Rev Immunol       Date:  2011-06-17       Impact factor: 53.106

Review 5.  Gut microbes and adverse food reactions: Focus on gluten related disorders.

Authors:  Heather J Galipeau; Elena F Verdu
Journal:  Gut Microbes       Date:  2014

Review 6.  Are stem cells a potential therapeutic tool in coeliac disease?

Authors:  Rachele Ciccocioppo; Giuseppina Cristina Cangemi; Emanuela Anna Roselli; Peter Kruzliak
Journal:  Cell Mol Life Sci       Date:  2014-12-16       Impact factor: 9.261

Review 7.  Effector and suppressor T cells in celiac disease.

Authors:  Giuseppe Mazzarella
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

Review 8.  The roles of MHC class II genes and post-translational modification in celiac disease.

Authors:  Ludvig M Sollid
Journal:  Immunogenetics       Date:  2017-07-10       Impact factor: 2.846

Review 9.  Innate immunity: actuating the gears of celiac disease pathogenesis.

Authors:  Sangman Michael Kim; Toufic Mayassi; Bana Jabri
Journal:  Best Pract Res Clin Gastroenterol       Date:  2015-05-11       Impact factor: 3.043

Review 10.  Triggers and drivers of autoimmunity: lessons from coeliac disease.

Authors:  Ludvig M Sollid; Bana Jabri
Journal:  Nat Rev Immunol       Date:  2013-03-15       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.